These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1385867)

  • 1. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.
    Kelly AB; Maraganore JM; Bourdon P; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6040-4. PubMed ID: 1385867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons.
    Kelly AB; Marzec UM; Krupski W; Bass A; Cadroy Y; Hanson SR; Harker LA
    Blood; 1991 Mar; 77(5):1006-12. PubMed ID: 1995089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.
    Cadroy Y; Maraganore JM; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1177-81. PubMed ID: 1996320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates.
    Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA
    Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
    Cadroy Y; Houghten RA; Hanson SR
    J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
    Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH
    Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons.
    Lumsden AB; Kelly AB; Schneider PA; Krupski WC; Dodson T; Hanson SR; Harker LA
    Blood; 1993 Apr; 81(7):1762-70. PubMed ID: 8461462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of local inhibition of procoagulant activity associated with small-diameter prosthetic vascular grafts.
    Oltrona L; Eisenberg PR; Abendschein DR; Rubin BG
    J Vasc Surg; 1996 Oct; 24(4):624-31. PubMed ID: 8911411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
    Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
    J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates.
    Cadroy Y; Hanson SR; Kelly AB; Marzec UM; Evatt BL; Kunicki TJ; Montgomery RR; Harker LA
    Blood; 1994 Jun; 83(11):3218-24. PubMed ID: 8193356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
    Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for inhibiting the effects of thrombin.
    Harker LA
    Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S47-58; discussion S59-64. PubMed ID: 8186356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
    Hortin GL; Trimpe BL
    J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A four-hour infusion of recombinant hirudin results in long-term inhibition of arterial-type thrombosis in baboons.
    Kotzé HF; Lamprecht S; Badenhorst PN
    Blood; 1995 Jun; 85(11):3158-63. PubMed ID: 7756648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates.
    Cadroy Y; Hanson SR; Harker LA
    Arterioscler Thromb; 1993 Aug; 13(8):1213-7. PubMed ID: 8343496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
    Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3184-8. PubMed ID: 3362867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effects of synthetic pentasaccharide with high affinity for plasma antithrombin III in non-human primates.
    Cadroy Y; Hanson SR; Harker LA
    Thromb Haemost; 1993 Oct; 70(4):631-5. PubMed ID: 8115989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors.
    Dichek DA; Anderson J; Kelly AB; Hanson SR; Harker LA
    Circulation; 1996 Jan; 93(2):301-9. PubMed ID: 8548903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.